LAKE ZURICH, Ill., Oct. 18 /PRNewswire/ — Fenwal, Inc., a
global medical technology company focused on improving blood
collection, separation, safety and availability, announced today it
has signed a three-year, exclusive agreement with AccuVein LLC to
sell, market and distribute the AccuVein AV300 vein illumination
device to blood and plasma centers in North America.
(Photo: http://photos.prnewswire.com/prnh/20101018/CG83159)
(Photo: http://www.newscom.com/cgi-bin/prnh/20101018/CG83159)
The AccuVein AV300 is the first hand-held, non-contact, vein
illumination device designed to assist medical professionals in
locating veins for blood donation, injection and for starting
patients on intravenous fluids.
Held about seven inches above the skin, the device detects
hemoglobin in veins and projects a map of the veins on the skin’s
surface. For medical professionals, donors and patients, this
can make locating needle placement a much easier and more
comfortable experience.
The AccuVein AV300 received the 2010 Medical Design Excellence
Award, the premier awards program for the medical technology
community, and was named a 2009 Best New Product for Pediatricians
by Contemporary Pediatrics magazine.
“The response to the AccuVein AV300 in tests with U.S. blood
centers was overwhelmingly positive,” said Dean Gregory, Fenwal
senior vice president of Commercial Operations. “Staff and
donors see this as an innovation that makes an immediate difference
in donor comfort, while improving center productivity and
increasing collections.”
In evaluations during two community blood drives, the device
helped increase collections by reducing by 75 percent deferrals due
to difficulty with vein location. In a recent AccuVein
survey, eight out of 10 blood don
‘/>”/>
SOURCE
